TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
BioPhausia AB
Closing information (x1000 NOK)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover |
143,757
|
179,513
|
203,625 |
Financial expenses |
195
|
584
|
201 |
Earnings before taxes |
88,091
|
112,594
|
127,674 |
EBITDA |
88,511
|
113,150
|
126,559 |
Total assets |
270,924
|
296,395
|
326,859 |
Current assets |
265,568
|
290,587
|
323,656 |
Current liabilities |
124,908
|
127,846
|
174,128 |
Equity capital |
146,015
|
166,133
|
150,551 |
- share capital |
488
|
524
|
473 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency |
53.9%
|
56.1%
|
46.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
61.3%
|
62.7%
![]() |
62.7% |
Return on assets (ROA) |
32.6%
|
38.2%
|
39.1% |
Current ratio |
212.6%
|
227.3%
|
185.9% |
Return on equity (ROE) |
60.3%
|
67.8%
|
84.8% |
Change turnover |
-23,354
|
-46,153
|
2,233 |
Change turnover % |
-14%
|
-20%
|
1% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.